SUNPHARMA Share Price Performance
₹1,629.70
-90.65 (-5.27%)
17.5% undervalued intrinsic discount
₹1,974.49
Fair Value
Price ₹1,629.70
AnalystConsensusTarget ₹1,974.49
Fair Value₹1,974.49
Share Price₹1,629.70
17.5% undervalued intrinsic discount
SUNPHARMA Community Narratives
AN
Fair Value ₹1.97k 17.5% undervalued intrinsic discount
Efficient R&D And Specialty Pipeline Expansion Will Strengthen Future Competitive Positioning
0users have liked this narrative
0users have commented on this narrative
14users have followed this narrative
SUNPHARMA Community Fair Values
- ₹1.97kFV17.5% undervalued intrinsic discount9.48%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative14users have followed this narrative4 days ago author updated this narrative
Recent SUNPHARMA News & Updates
No updates
Sun Pharmaceutical Industries Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 43.23
- Gross Margin
- 78.25%
- Net Profit Margin
- 19.29%
- Debt/Equity Ratio
- 3.3%
Sun Pharmaceutical Industries Limited Competitors
About SUNPHARMA
- Founded
- 1983
- Employees
- 43000
- CEO
- WebsiteView website
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, urology, dermatology, respiratory, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. It exports its products to approximately 90 countries across Asia, North America, Europe, Africa, South America, and Australia. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.
Indian Market Performance
- 7 Days: -1.6%
- 3 Months: 2.7%
- 1 Year: -6.5%
- Year to Date: -2.0%
Over the last 7 days, the market has dropped 1.6%, driven by a decline of 2.1% in the Financials sector. As for last year, the market is also down 6.5%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading